Results 171 to 180 of about 3,293,378 (262)

Real-world use of biologic and targeted synthetic disease-modifying antirheumatic drugs in US patients with psoriatic arthritis: Persistence, patient characteristics associated with discontinuation, and dosing patterns. [PDF]

J Manag Care Spec Pharm
Merola JF, Welby S, Roque H, Song J, Pilipczuk O, Lu C, Walsh JA.   +6 more
europepmc   +1 more source

Retention Rates of Biological Drugs in Spondyloarthritis: A 24-Month Observational Study in Patients Aged 60 Years or Older. [PDF]

Drugs Real World Outcomes
Foti R, De Lucia F, Amato G, Visalli E, Dal Bosco Y, Aiello F, Paolì MG, Privitera G, Montana A, Foti R.   +9 more
europepmc   +1 more source

Comparison of long-term efficacy, tolerability and drug survival rates of baricitinib as monotherapy or combination therapy in RA patients: data from a real-world prospective cohort study. [PDF]

RMD Open
Temiz A, Tascilar K, Kleyer A, Hueber AJ, Hartmann F, Schett G, Bayat S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug therapy reviews: Antirheumatic agents

American Journal of Health-System Pharmacy, 1979
The pathophysiology, symptoms and drug treatment of rheumatic disease are reviewed. Antirheumatic drugs reviewed are salicylates (including aspirin, sodium salicylate, choline salicylate, choline magnesium salicylate, salsalate), phenylpropionic acid derivatives (fenoprofen, ibuprofen, naproxen), indole derivatives (sulindac, tolmetin and indomethacin),
R. Evens
openaire   +3 more sources

New Antirheumatic Agents

JAMA, 1977
The new antirheumatic agents, fenoprofen calcium, naproxen, and tolmetin sodium, are effective in the management of rheumatoid arthritis. Their efficacy is comparable, but not superior, to that of aspirin in usual oral doses. These agents also may be useful in degenerative joint disease and ankylosing spondylitis and as analgesics and antipyretics ...
J. Lewis
openaire   +3 more sources

Articular Pharmacokinetics of Protein-Bound Antirheumatic Agents

Clinical Pharmacokinetics, 1993
By what mechanism do nonsteroidal anti-inflammatory drugs (NSAIDs) move from plasma into synovial fluid and back, and how does binding to plasma albumin in vitro relate to articular transport in vivo? To evaluate these issues, concurrent plasma and synovial fluid data of 8 different NSAIDs from 10 single-dose trials were analysed by a simple ...
P A, Simkin, M P, Wu, D M, Foster
openaire   +3 more sources